Sputnik V - Third vaccine against COVID19 in India

"The first dose of Sputnik V vaccine was administered in Hyderabad”

Sputnik V is the third COVID19 vaccine available in India after Covaxin and Covishield. It is made by Gamaleya Research Institute of Epidemiology and Microbiology, Moscow. It is a two-dose vaccine same as Covishield and Covaxin. This vaccine has an efficacy of 91% as per the researchers. Dr. Reddy’s Laboratories has received 1,50,000 doses of this vaccine from Russia. However, the company expects more doses of it in near future. The first dose of Sputnik V was administered in Hyderabad. 

This vaccine is costing Rs. 995 per dose, this includes 5% of GST. Covishield which is being manufactured by Serum Institute of India, Pune is costing Rs. 300 per dose to States and Rs. 600 per dose to private hospitals. Covaxin is priced at Rs. 400 per dose to States and Rs. 1200 per dose to private hospitals. However, Dr. Reddy’s Laboratories has set the same price for Government and private channels. 

20% initial supply of Sputnik V will be imported from Russia. “There is a commitment of 36 million doses from RDIF (Russian Direct Investment Fund) in next 2 months”, said Vice President, Dr. Reddy’s. The laboratory will soon bring single dose Sputnik Light vaccine in India.

Tags : #Spotlight #SputnikV #DRL #Covishield #PriceofSputnik #FirstdoseofSputnik #Medicircle #SmitaKumar

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Achieving Healthier Lifestyles: Understanding India's New Dietary GuidelinesMay 11, 2024
The Link Between Childhood Sleep and Adult Psychosis: A Critical AnalysisMay 11, 2024
Uncovering Immunization Gaps: Insights into Measles Vaccination Challenges in IndiaMay 11, 2024
Unlocking New Horizons: Gene Therapies for Hearing Loss and BlindnessMay 10, 2024
Kerala Health Alert: West Nile Fever Cases Confirmed in Thrissur, Malappuram, and KozhikodeMay 10, 2024
Managing Health in the Heat: Demand for Medications Surges in IndiaMay 10, 2024
Sudhamukti Ayurvedic Medicine by OJSP: A New Era in Diabetes ManagementMay 10, 2024
The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
Reducing Stigma, One Story at a Time: Media's Role in Mental HealthMay 07, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024